Successful use of infliximab in a patient with neuro-Behcet's disease

被引：13

作者：

Abalos-Medina, Gracia Maria ^{[1
]}

Sanchez-Cano, Daniel ^{[1
]}

Ruiz-Villaverde, Gonzalo ^{[1
]}

Ruiz-Villaverde, Ricardo ^{[1
]}

Quirosa Flores, Susana ^{[1
]}

Raya Alvarez, Enrique ^{[1
]}

机构：

[1] Hosp Clin San Cecilio, Serv Reumatol, Granada 18012, Spain

来源：

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2009年 / 12卷 / 03期

关键词：

Infliximab; neuro-Behcet's disease; NECROSIS-FACTOR-ALPHA; OF-THE-LITERATURE; NEUROLOGICAL INVOLVEMENT; NERVOUS-SYSTEM; EFFICACY; BLOCKADE; THERAPY;

D O I：

10.1111/j.1756-185X.2009.01420.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Behcet's disease (BD) is a systemic vasculitic disorder of unknown aetiology characterised by recurrent oral and often genital ulcers, which may be associated with ocular, cutaneous, articular, neurological or vascular involvement. We report a 52-year-old woman diagnosed of neuro-BD who was treated with infliximab with a dramatic response to this treatment.

引用

页码：264 / 266

页数：3

共 50 条

[21] Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behcet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis
Kurata, Izumi
Tsuboi, Hiroto
Takahashi, Hidenori
Abe, Saori
Ebe, Hiroshi
Hagiwara, Shinya
Umeda, Naoto
Kondo, Yuya
Ogishima, Hiroshi
Suzuki, Takeshi
Matsumoto, Isao
Hoshi, Sujin
Oshika, Tetsuro
Sumida, Takayuki
INTERNAL MEDICINE, 2015, 54 (12) : 1553 - 1557
[22] Tocilizumab for severe refractory neuro-Behcet: Three cases IL-6 blockade in neuro-Behcet
Addimanda, Olga
Pipitone, Nicolo
Pazzola, Giulia
Salvarani, Carlo
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (04) : 472 - 475
[23] Primary Headache in Behcet's and Neuro-Behcet's Disease
Beton, Ozlem Ergin
Yucesan, Canan
NEUROLOGY INDIA, 2022, 70 (01) : 254 - 257
[24] Neuro-Behcet's Disease: An Unusual Cause of Headache
Fountain, Eric Michael
Dhurandhar, Anjali
JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 (06) : 956 - 960
[25] Infliximab therapy in parenchymal neuro-Behcet's disease: A single-center experience
Kehribar, Demet Yalcin
Gunaydin, Serkan
Ozgen, Metin
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (10) : 1302 - 1307
[26] Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease
Borhani-Haghighi, Afshin
Safari, Anahid
CLINICAL RHEUMATOLOGY, 2010, 29 (06) : 683 - 686
[27] Infliximab for reversible dementia in acute onset of neuro-Behcet's disease: A case report and cytokine analysis
Imabayashi, Keisuke
Ayano, Masahiro
Higashioka, Kazuhiko
Yokoyama, Kana
Yamamoto, Ken
Takayama, Koji
Mitoma, Hiroki
Kimoto, Yasutaka
Akahoshi, Mitsuteru
Arinobu, Yojiro
Akashi, Koichi
Horiuchi, Takahiko
Niiro, Hiroaki
JOURNAL OF NEUROIMMUNOLOGY, 2021, 357
[28] Cortical and cerebellar atrophy, but no lesion in a patient with neuro-Behcet's disease
Varoglu, Asuman Orhan
Aksoy, Asude
Kocaturk, Idris
Ertekin, Ayfer
Koplay, Mustafa
Odabas, Faruk Omer
Ozbek, Seda
WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (11-12) : 326 - 327
[29] Acute/subacute Neuro-Behcet's disease
Kontzialis, Marinos
Guryildirim, Melike
ACTA NEUROLOGICA BELGICA, 2017, 117 (04) : 925 - 926
[30] Cytotoxic Edema in Neuro-Behcet's Disease ?
Shrestha, Isha
Ohshita, Tomohiko
Naka, Hiromitsu
Morino, Hiroyuki
Matsumoto, Masayasu
INTERNAL MEDICINE, 2008, 47 (23) : 2073 - 2076

← 1 2 3 4 5 →